KUALA LUMPUR (Feb 27): The arrival of Sinovac Covid-19 vaccine marked a historic moment for Malaysia and an important milestone for Pharmaniaga Bhd’s venture into vaccine manufacturing as it will be the first-ever vaccine to be filled and finished locally.
Pharmaniaga LifeScience Sdn Bhd (PLS), a wholly-owned subsidiary of Pharmaniaga today received the first batch of Sinovac Covid-19 vaccine bulk for the purpose of process validation (PV) batch manufacturing.
PV is part of the registration application requirement by the National Pharmaceutical Regulatory Agency (NPRA).
The 200-litre bulk equalling to 300,000 doses of vaccine, arrived in an envirotainer, which preserves the vaccine temperature between 2 to 8 degrees Celsius, was flown in by MASkargo on an Airbus A330-300 from Beijing, China.
Ten media representatives and several healthcare personnel were among the first group to receive the Pfizer-BioNTech vaccine under the National Immunisation Programme in Labuan, Saturday
Media personnel, frontliners among first vaccinated in Labuan
February 27, 2021
LABUAN – Ten media representatives and several healthcare personnel were among the first group to receive the Pfizer-BioNTech vaccine under the National Immunisation Programme in Labuan today.
Others joining the queue were Labuan Corporation Advisory Council chairman Senator Datuk Bashir Alias, Labuan MP Datuk Rozman Isli, Labuan Natural Disaster Management Committee chairman Rithuan Ismail, Labuan police chief DSP Mohd Ibrahim Mohd Ghani and Labuan National Security Council director Mohd Hafiez Daud.
Advertisement
Members of the media were from the Malaysian National News Agency (Bernama), Radio Televisyen Malaysia (RTM) and the Information Department, all based in Labuan.
Arrival of Sinovac vaccine an important milestone for Pharmaniaga s vaccine manufacturing venture thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.
Join Reseller News
Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.Sign up now
Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
26 February 2021 16:34
Meningococcal Vaccine Market Insights and Forecast 2020 to 2027
Latest Study on Meningococcal Vaccine Market Size, Share, Growth, Trends, Production, Consumption, Revenue and Forecast 2020 to 2027 .
The global meningococcal vaccine market size is projected to reach around USD 4,192.6 million by 2027, registering a CAGR of 9.6% from 2020 to 2027.
The global meningococcal vaccine market is expected to experience significant market growth during the forecast period as there has been an increase in adoption in several countries across the globe in their national immunization programs. In addition, surge in meningococcal outbreaks in several countries has led to upsu